DAVION HEALTHCARE £30 MILLION SENIOR SECURED BOND ADMITTED TO TRADING ON VIENNA MTF

Davion Healthcare Plc has announced the successful admission of a £30 million senior secured bond issued by its financing subsidiary, Davion Healthcare Finance Ltd, to trading on the Vienna MTF. This transaction, which took place on September 14, 2026, is designed to bolster the company’s acquisition-led growth strategy within the healthcare sector. The five-year bond, which commenced in August 2026, features a fixed annual coupon of 10.5%, providing Davion with a dedicated source of capital for future acquisitions.

Davion Healthcare Plc, based in Dublin, focuses on the development and commercialization of healthcare technologies and products. The company aims to expand its international commercial capabilities while pursuing an aggressive acquisition strategy targeting established healthcare businesses. The proceeds from this bond will be utilized to acquire companies and assets within various healthcare subsectors, including medical devices, diagnostics, healthcare technology, and healthcare services. The strategic focus is on cash-generative businesses that can contribute earnings from day one, thereby enhancing Davion’s portfolio and distribution capabilities.

The issuance of the bond reflects a broader trend in the healthcare sector, where companies are increasingly seeking to consolidate and expand their market presence through acquisitions. As healthcare continues to evolve with technological advancements and shifting regulatory landscapes, companies like Davion are positioning themselves to capitalize on opportunities that arise from market consolidation. The fixed coupon rate of 10.5% indicates a strong investor interest in the bond, suggesting confidence in Davion’s growth strategy and potential for future profitability.

The admission of the bond to trading on the Vienna MTF not only provides Davion with immediate capital but also enhances its visibility in the financial markets. This move is expected to attract further investor interest, supporting the company’s long-term objectives of building a larger and more diversified international healthcare business. As Davion evaluates various acquisition opportunities, the bond financing will enable it to act swiftly in a competitive landscape.

Overall, this transaction underscores the ongoing dynamism within the healthcare sector, where access to capital remains crucial for companies aiming to expand their operations and innovate. As Davion Healthcare Plc embarks on its acquisition strategy, the successful placement of the bond may serve as a bellwether for similar financing activities in the sector, highlighting the importance of strategic capital deployment in achieving growth objectives.